Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMOZOLOMIDE Cause Product use in unapproved indication? 1,353 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,353 reports of Product use in unapproved indication have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 8.0% of all adverse event reports for TEMOZOLOMIDE.

1,353
Reports of Product use in unapproved indication with TEMOZOLOMIDE
8.0%
of all TEMOZOLOMIDE reports
82
Deaths
80
Hospitalizations

How Dangerous Is Product use in unapproved indication From TEMOZOLOMIDE?

Of the 1,353 reports, 82 (6.1%) resulted in death, 80 (5.9%) required hospitalization, and 36 (2.7%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 1,353 reports have been filed with the FAERS database.

What Other Side Effects Does TEMOZOLOMIDE Cause?

Disease progression (1,562) Death (1,403) Off label use (1,357) Thrombocytopenia (1,300) Drug ineffective (1,131) Nausea (1,071) Neutropenia (809) Malignant neoplasm progression (779) Fatigue (766) Vomiting (697)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which TEMOZOLOMIDE Alternatives Have Lower Product use in unapproved indication Risk?

TEMOZOLOMIDE vs TEMSIROLIMUS TEMOZOLOMIDE vs TENAMFETAMINE TEMOZOLOMIDE vs TENAPANOR TEMOZOLOMIDE vs TENECTEPLASE TEMOZOLOMIDE vs TENELIGLIPTIN

Related Pages

TEMOZOLOMIDE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication TEMOZOLOMIDE Demographics